Burden of skin disease and associated socioeconomic status in Europe: An ecologic study from the Global Burden of Disease Study 2017

Abstract

Introduction: Dermatoses contribute to a large burden of global disease, but the relationship between socioeconomic status and the effect of dermatologic conditions in Europe is not well understood. Methods: We selected Global Burden of Disease Study data sets to analyze disability-adjusted life-years (DALYs) and the annual rate of change of dermatoses between 1990 and 2017 in 43 European countries. The principal country-level economic factor used was gross domestic product per capita from the World Bank. Statistical analysis was performed with Spearman r correlation. Results: Wealthier European countries had higher DALYs for melanoma, basal cell carcinoma, psoriasis, atopic dermatitis, acne, seborrheic dermatitis, alopecia, asthma, contact dermatitis, and viral skin disease. Poorer countries had higher DALYs of squamous cell carcinoma, urticaria, decubitus ulcers, pruritus, scabies, tuberculosis, and syphilis. Thirteen European countries were in the top 10th percentile globally for annual increase in skin and subcutaneous disease burden. Conclusion: The majority of European countries have experienced an increase in skin and subcutaneous diseases in recent decades relative to the rest of the world, but the burden of individual dermatoses in Europe varies by country and socioeconomic status. DALYs can potentially serve as a purposeful measure for directing resources to improve the burden of skin disease in Europe. (JAAD Int 2020;1:95-103.)

Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years

“…In the United States, it is estimated that the total annual spending related to NMSC was 650 million US dollars, and the cost of health insurance is 6–7 times that of treating melanoma [ 9 ]. Furthermore, the disease burden has increased in recent years [ 32 , 33 ]. Between 1997 and 2010, the treatment of NMSC increased by 86% [ 34 ].…”

Prevalence of Skin Disease and Its Associated Factors Among Primary Schoolchildren: A Cross-Sectional Study from a Northern Ethiopian Town

“…Second, social desirability bias will be there with potential over-reporting of favorable behaviors regarding hygienic practice, for which controlling was difficult. The wealth index, which will be the main factor in developing skin disorders, 28 was not also assessed in this study.…”

Nanodelivery Strategies for Skin Diseases with Barrier Impairment: Focusing on Ceramides and Glucocorticoids

“…AD-related out-of-pocket costs pose an extra spending mean amount of €927 by every patient per year [5]. In Europe, AD and psoriasis represent the skin diseases that triggered the most visits to the dermatologist [6], with the burden of psoriasis being greater in patients from European high-income countries [7]. In the European Union, the economic burden of psoriasis per patient/year varies from €5000 (Germany) to €12,000 (Sweden), while the total cost of psoriasis therapy is more than $50 billion per year in the United States of America [8].…”